Blood stem cell transplantation for patients with MS
The project investigates expectations, quality of life and psychological well-being among patients with MS undergoing blood stem cell transplantation
Details
- Funder: Stiftelsen Uppsala Sjuksköterskehem
Description
This research project investigates expectations, health-related and individual quality of life, and psychological wellbeing among patients with MS (multiple sclerosis) before and after receiving autologous blood stem cell transplantation.
The project is a prospective, longitudinal and descriptive study, using both quantitative and qualitative methods for data collection and analysis.
More about the project
Multiple sclerosis (MS) is an autoimmune disease affecting the central nervous system. Treatments for MS are preventive and aims to slow disease progression and prevent further damage on the central nervous system. Autologous stem cell transplantation (AHSCT) has been shown to be effective for patients with relapsing MS with high disease activity.
Expectations on the treatment, and the implications of such expectations on the results of the treatment has been studied to a very limited extent. Unrealistic expectations on the treatment, and ending treatment to slow disease progression may result in symptoms of anxiety and/or depression, and subsequently have negative effects on psychological well-being and quality of life.
As such, the project aims to explore and describe expectations, health-related quality of life and psychological well-being among patients with MS before and after treatment with AHSCT.
%20(2)%20BATV6288-800px.jpg)